NUWE Nuwellis, Inc. logo

NUWE Nuwellis, Inc.

Healthcare
$1.05+5.37%ClosedMarket Cap: $947,798

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.76

P/S

0.11

EV/EBITDA

0.07

DCF Value

$-0.60

FCF Yield

-1214.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

65.5%

Operating Margin

-141.5%

Net Margin

-214.9%

ROE

-17015.8%

ROA

-263.0%

ROIC

-335.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$2.4M$-4.3M$
Q4 null$2.4M$-2.4M$
FY null$8.3M$-17.5M$
Q3 null$2.2M$468.0K$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
WALLER GREGORY Ddirector
SellWed Apr 29
McDonald Daviddirector
SellWed Apr 29
Feldshon Archelle Georgioudirector
SellWed Apr 29
Emerson Martin Jdirector
SellWed Apr 29
Emerson Martin J
SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.25

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Peers